BioScrip, Inc. (BIOS) has 93 open-market insider trades by 32 insiders since 2006. The most active filer is Richard H. Friedman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Partners V. L.p. Kohlberg | 10% | — | 1 | $89.6M | 2013-08-19 |
| Offshore Investors V. L. P. Kohlberg | 10% | — | 1 | $45.2M | 2013-04-24 |
| Adam Gray | Dir10% Owner | — | 2 | $13.9M | 2019-06-10 |
| Coliseum Capital, LLC | Dir10% Owner | — | 1 | $8.4M | 2016-06-22 |
| Christopher S. Shackelton | Dir10% Owner | — | 2 | $6.3M | 2019-08-06 |
| Richard H. Friedman | — | — | 23 | $5.6M | 2012-04-18 |
| William J. Nasgovitz | — | — | 10 | $4.6M | 2010-02-01 |
| Stanley Rosenbaum | — | — | 3 | $1.5M | 2010-12-28 |
| Coliseum Capital Management, LLC | Dir10% | — | 1 | $724K | 2017-08-15 |
| Patricia Bogusz | PresFinance | — | 2 | $579K | 2013-08-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Stephen Deitsch | CFO | Buy | $20K | 2017-11-09 |
| Daniel E. Greenleaf | CEO | Buy | $30K | 2017-11-09 |
| Michael G. Bronfein | Director | Sell | $73K | 2017-09-15 |
| Adam Gray | Director & 10% Owner | Sell | $12.7M | 2017-09-05 |
| Christopher S. Shackelton | Director & 10% Owner | Sell | $4.8M | 2017-08-15 |
| Jeffrey M. Kreger | CFO | Buy | $13K |
Companies that share insiders with BIOS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2016-11-11 |
| R. Carter Pate | Director | Buy | $26K | 2016-11-10 |
| Daniel E. Greenleaf | CEO | Buy | $21K | 2016-11-10 |
| Coliseum Capital, LLC | Director & 10% Owner | Buy | $8.4M | 2016-06-22 |
| Michael G. Bronfein | Director | Buy | $200K | 2016-06-17 |
| Michael Goldstein | Director | Buy | $125K | 2016-06-17 |
| David W. Golding | Director | Buy | $31K | 2016-06-17 |
| R. Carter Pate | Director | Buy | $63K | 2016-06-17 |
| Christopher S. Shackelton | Director & 10% | Buy | $1.5M | 2015-08-24 |
| Coliseum Capital Management, LLC | Director & 10% | Buy | $724K | 2015-08-21 |